Loading stock data…
$0.68-0.01 (-1.82%)
Lakewood-Amedex Biotherapeutics, Inc.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$3.79M↓ | -$886,750↓ | -$712,060↑ | -$1.88M↓ | -$637,384 |
| Net Income | -$3.77M↓ | -$923,291↓ | -$744,918↑ | -$1.91M↓ | -$655,943 |
Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broa...